New pill aims to keep pneumonia patients out of hospital
NCT ID NCT06202521
Summary
This study tested whether adding an experimental drug called silmitasertib to standard care could help adults with pneumonia caused by COVID-19 or the flu. The goal was to see if the combination treatment could prevent patients from getting worse and needing to go to the hospital. The trial was stopped early and involved comparing the drug to a placebo in a small group of outpatients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMMUNITY ACQUIRED PNEUMONIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Far Eastern Memorial Hospital
New Taipei City, Taiwan
-
Kaohsiung Veterans General Hospital
Kaohsiung City, Taiwan
-
National Taiwan University Cancer Center, National Taiwan University Hospital
Taipei, Taiwan
-
National Taiwan University Hospital
Taipei, Taiwan
-
Taichung Veterans General Hospital
Taichung, Taiwan
-
Taoyuan General Hospital, Ministry of Health and Welfare
Taoyuan District, Taiwan
-
Tri-Service General Hospital
Taipei, Taiwan
Conditions
Explore the condition pages connected to this study.